Pfizer earnings jump by 46%

PFIZER INC’S fourth-quarter earnings climbed 46% as the world’s largest drug-maker sold more of the epilepsy treatment neurontin and the cholesterol medicine lipitor.

Pfizer earnings jump by 46%

The company, which boasts 10 prescription drugs, that each generated more than $1 billion in revenue last year, saw net income rise to $2.86 billion, or 46 cents a share, from $1.96 billion, or 30 cents, in the year-earlier period.

Revenue increased 14% to $9.3 billion. Pfizer employs 1,200 people in Ireland. Top-selling drug lipitor is made at the Loughbeg Tablet plant in Cork and is expected to be the biggest-selling prescription drug on the market by the end of the year. The main ingredients for impotence treatment drug

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited